Clicky

PTC Therapeutics, Inc.(PTCT) News

Date Title
May 22 Those who invested in PTC Therapeutics (NASDAQ:PTCT) three years ago are up 51%
May 10 PTC Therapeutics, Inc. (PTCT): Among Billionaire David E. Shaw’s Small-Cap Stock Picks with Huge Upside Potential
May 7 PTC Therapeutics: Q1 Earnings Snapshot
May 7 PTC Therapeutics Inc (PTCT) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...
May 6 PTC Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
May 6 PTC Therapeutics price target lowered to $57 from $65 at RBC Capital
May 5 Why Did PTC Therapeutics Stock Fall On Monday Despite Mid-Stage Study For Huntington's Hits Primary Goal?
May 5 PTC stock slides on new data for Huntington’s drug
May 5 PTC518 PIVOT-HD Study Achieves Primary Endpoint
Mar 20 PTC Therapeutics Presents New Sepiapterin Data from Ongoing Studies
Feb 24 Countdown to PTC Therapeutics (PTCT) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS
Feb 20 PTC Therapeutics to Participate in Upcoming Investor Conferences
Feb 19 PTC Therapeutics Announces FDA Acceptance and Priority Review for Vatiquinone NDA for the Treatment of Children and Adults with Friedreich's Ataxia
Feb 13 PTC Therapeutics to Host Conference Call to Discuss Fourth Quarter and Full Year 2024 Financial Results
Oct 9 PTC Therapeutics Inc (PTCT) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and ...
Oct 9 PTC Therapeutics (PTCT) Surges 16.5%: Is This an Indication of Further Gains?
Oct 9 PTCT Stock Rises on Positive Updates on Friedreich Ataxia Program
Oct 8 Sector Update: Health Care Stocks Rise Late Afternoon
Oct 8 PTC Therapeutics Announces Positive Results from Long-Term Treatment Studies and Updates on Regulatory Progress for Vatiquinone Friedreich Ataxia Program
Oct 4 3 Top Stocks That Could Still Rocket Higher in 2024